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PENGARUH KEPEKATAN LARUTAN KALSIUM FOSFAT BERASID 
TERHADAP SIFAT-SIFAT PELET Β-TRIKALSIUM FOSFAT  
DISALUTI DIKALSIUM FOSFAT DIHIDRAT 
ABSTRAK 
Matlamat kajian ini adalah untuk mengkaji kesan kepekatan larutan kalsium 
fosfat berasid dalam penghasilan pelet β-trikalsium fosfat yang disaluti oleh dikalsium 
fosfat dihidrat (DCPD). Pelet β-TCP akan didedahkan kepada larutan kalsium fosfat 
berasid selama 1, 3 dan 5 jam bagi menghasilkan lapisan salutan DCPD di atas pelet 
β-TCP melalui tindak balas penguraian-pemendakan. Beberapa kaedah pencirian 
seperti Pembelauan Sinar-X (XRD), Spektroskopi Inframerah Transformasi Fourier 
(FTIR), Mikroskop Elektron Imbasan (SEM), Mikroskop Daya Atom (AFM), analisis 
keliangan dan ujian mampatan telah dijalankan ke atas spesimen. Analisa XRD dan 
SEM menunjukkan jumlah kristal DCPD yang termendak di atas pelet akan meningkat 
apabila kepekatan larutan kalsium fosfat berasid ditingkatkan. Peningkatan jumlah 
pembentukan DCPD akan mengurangkan keliangan sehingga 20% dan meningkatkan 
kekuatan mekanikal spesimen hingga mencapai 40%. Sementara itu, analisis XRD dan 
SEM menunjukkan bahawa pembentukkan hidroksiapatit (HAp) akan meningkat 
apabila masa rendaman bagi pelet β-TCP yang didedahkan selama 3 jam dengan 
menggunakan kepekatan larutan kalsium fosfat berasid yang berbeza dalam larutan 
garam seimbang Hank (HBSS) ditingkatkan pada keadaan fisiologi badan. Oleh itu, 
berdasarkan kajian ini menunjukkan bahawa jumlah penghasilan salutan DCPD di atas 
pelet β-TCP dapat dikawal dengan mengubah kepekatan larutan kalsium fosfat berasid 
yang dapat mencetuskan pembentukan HAp pada keadaan fisiologi badan. 
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INFLUENCE OF ACIDIC CALCIUM PHOSPHATE SOLUTION 
CONCENTRATION ON THE PROPERTIES OF DICALCIUM PHOSPHATE 
DIHYDRATE COATED ON Β-TRICALCIUM PHOSPHATE PELLETS 
ABSTRACT 
The aim of this study is to investigate the effect of acidic calcium phosphate 
solution concentration in fabricating dicalcium phosphate dihydrate (DCPD) coated 
on β-TCP pellets. β-TCP pellets were exposed to an acidic calcium phosphate solution 
for 1, 3 and 5 hours in order to obtain DCPD-coated layer on β-TCP pellets through 
dissolution-precipitation reaction. Several characterization methods such as X-Ray 
Diffraction (XRD), Fourier-Transform Infrared Spectroscopy (FTIR), Scanning 
Electron Microscope (SEM), Atomic Force Microscope (AFM), porosity analysis and 
compression test were carried out on specimen. The analyses of XRD and SEM 
showed that the amount of DCPD crystal precipitated on the pellets were increased 
when increasing the acidic calcium phosphate solution concentration. Increasing the 
amount of DCPD formation will reduced the porosity until 20% and increased the 
mechanical strength of specimen up to 40%. Meanwhile, XRD and SEM analyses 
showed that hydroxyapatite (HAp) formation were increased after increasing the 
soaking time of β-TCP pellet treated for 3 hours using different concentration of acidic 
calcium phosphate solution in Hank’s Balanced Salt Solution (HBSS). Therefore, 
based on this study shows that the amount of DCPD coated on β-TCP pellet could be 
regulated by changing the concentration of acidic calcium phosphate solution that 
induced HAp formation at physiological body condition. 
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CHAPTER 1  
 
 
INTRODUCTION 
1.1 Background of Research 
Calcium phosphate (CaP) is one of the promising bone substitute material that 
had been widely used in clinics and hospitals. This material are well known for their 
good biocompatibility inside the body (Kwon et al., 2003). In addition, calcium 
phosphate also have the ability to regenerate new bone formation when being 
implanted in the body (Dong et al., 2002). Moreover, CaP had bioactive properties 
where it can induced specific biologic response with living tissues (Veis et al., 2009). 
Besides, CaP also having an important roles in human and animal daily lives due to 
the main components of the bone and teeth containing calcium phosphate itself 
(Habraken et al., 2016). 
Currently, calcium phosphate bone substitute are being applied in various 
applications such as orthopaedic, dentistry and maxillofacial surgery. Also, CaP had 
widely studied as potential candidate for drug delivery application as they are 
compatible with the drugs (Cheng and Kuhn, 2007) such as gentamicin (Sundblom, 
Gallinetti, Birgersson, Engqvist, & Kihlström, 2019) and vancomycin (Uchida et al., 
2018).  Moreover, in the application of bone tissue engineering, CaP are mainly used 
as artificial bone substitute which help to induced formation of new bone (Canillas et 
al., 2017). Nowadays, calcium phosphate bone substitute materials has been produces 
in various shapes such as calcium phosphate cements (Xu et al., 2006), coatings (Paital 
and Dahotre, 2009), blocks (Lim et al., 2015), pellets (Baradari et al., 2012) and 
scaffolds (Shepherd and Best, 2011).  
2 
Beta-tricalcium phosphate (β-TCP) is one of the calcium phosphate that had 
been widely used due to their good biodegradability and biocompatibility despite 
higher dissolution after being implanted in the body. While dissolution process occurs 
in the body, osteoclast cell will resorbed the β-TCP and new bone formation will 
deposited on the β-TCP by osteoblast cells (Billington & Reid, 2019). Although, β-
TCP show good new bone formation after implantation, its osteoconductivity are still 
inferior with the natural bone after implantation takes place in the large bone defect 
area. Therefore, recent study by Shariff et al., (2017) reported that osteoconductivity 
of β-TCP bone substitute in large bone defect size (above 6mm) was improved after 
coating β-TCP granular surfaces with a layer of dicalcium phosphate dihydrate 
(DCPD). Based on this idea, in this study, influence of acidic calcium phosphate 
solution concentration in fabricating bi-layer DCPD-coated β-TCP pellet will be 
investigated and its biological response towards Hank’s Balanced salt Solution 
(HBSS) will be evaluated. 
1.2 Problem Statements 
Beta-tricalcium phosphate (β-TCP) had been widely used as artificial bone 
substitutes due to their similar chemical composition with natural bone. This 
advantages contributed to the good biocompatibility and osteoconductivity of β-TCP 
bone substitute. However, the new bone formation rate of β-TCP bone substitute is 
still inferior towards large bone defect size due to quick dissolution of β-TCP in large 
bone defect area (Zheng et al., 2014). Therefore, if new bone formation rate of β-TCP 
can be enhanced, its clinical applications could be enhanced.  
Recent study by Shariff et al., (2017) had reported that the osteoconductivity 
of β-TCP were improved by coating β-TCP granular surfaces with a layer of dicalcium 
3 
phosphate dihydrate (DCPD).  Histological evaluation using rats calvarial model 
shows that the β-TCP granules coated with 5 mass% amount of DCPD shows the 
largest new bone formation after implanted in rat calvarial for 2 and 4 weeks. Besides, 
in-vivo studies done by Fukuda et al., (2018) and Eddy et al., (2018) found that the 
presence of DCPD phase in β-TCP granular cement were significantly improved the 
new bone formation after implanted in 9 mm of rat calvarial bone defect size. Although 
this studies succeed to prove that DCPD phase can improved the new bone formation 
rate of β-TCP granular, there is no clearly study has been carried out in order to 
understand the correlation between in-vivo and in-vitro responses towards bi-layer 
DCPD-coated on β-TCP granular. Previous study had reported that the granular shape 
specimens show drawbacks during cell studies such as high probability of cells to be 
detached from the specimens due to the irregular shape of granules (Mebarki et al., 
2017). 
Meanwhile, there is a study reported that advantageous of pellet shape 
specimen for cell studies purposes. Study by Huang et al., (2017) found that cell can 
be easily attached on the pellet surface specimen during in-vitro study. This is due to 
the pellets shaped having flat shape surface while granules have irregular shape 
surface. Therefore, in this study, effect of acidic calcium phosphate concentration in 
fabricating bi-layer DCPD-coated on β-TCP pellet will be investigate and its biological 
activity will be tested using Hank’s Balanced Salt Solution (HBSS). 
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1.3 Research Objectives 
1. To investigate the effect of acidic calcium phosphate solution concentration 
in fabricating bi-layer DCPD-coated β-TCP pellet and its mechanical 
properties. 
2. To evaluate hydroxyapatite formation on bi-layer DCPD-coated β-TCP 
pellet after exposing with Hank’s Balanced Salt Solution at physiological 
body condition. 
1.4 Research Approach 
To determine the effect of acidic calcium phosphate solution in fabricating bi-
layer DCPD-coated β-TCP pellet. There are two different concentration of acidic 
calcium phosphate solution were used which 50 mmol/L MCPM–25 mmol/L H3PO4 
and 75mmol/L MCPM-25 mmol/L H3PO4. The exposure time for the coating process 
of DCPD on β-TCP pellet were set to at 1, 3 and 5 hours. 
From the first stage, the characterization of bi-layer DCPD-coated β-TCP pellet 
were examined using X-ray Diffraction (XRD) which used to analyse the phase 
compositional present in the pellet. The presence of functional group in the specimen 
was analysed using Fourier Transform Infrared spectroscopy (FTIR). The surface and 
cross section morphology of the pellets were examined using Field Emission Scanning 
Electron Microscopy (FESEM). Moreover, Atomic Force Microscopy (AFM) was 
used to analyse the surface topography and surface roughness of the specimens. The 
relationship between porosity and compressive strength test was conducted in order to 
evaluate the mechanical properties of the pellets. Next, the pH analysis was carried out 
to determine the pH value of the HBSS solution after being exposed with the pellets. 
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Then, dissolution behaviour of Ca and P ions for the specimens were measured using 
Inductive coupled plasma-optical emission spectrometry (ICP-OES). 
Based on the characterization in the first stage, specimen treated for 3 hours 
using both concentration of acidic calcium phosphate solution were selected for 
biological evaluation using HBSS solution at physiological body condition. 
Assessment of hydroxyapatite formation on the bi-layer DCPD-coated β-TCP pellet 
were evaluated using XRD, FTIR, FESEM and AFM. The method of producing bi-
layer DCPD-coated β-TCP pellet and its biological test were summarized in Figure 
1.1. 
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Figure 1.1: The flowchart process of fabricating bi-layer DCPD-coated β-TCP pellet 
                   and its characterization. 
 
 
 
Mixing (CaCO3 + DCPD + ethanol solution) Ca/P: 1.5 
Milling (Planetary ball mill at 200 rpm for 6 hours) 
Drying (60°C for 24 hours) 
Pressing (Pellet shape using hand press machine at 50 MPa) 
Sintering (1100°C for 6 hours) 
Fabrication of bi-layer DCPD-coated β-TCP pellet (immersed β-TCP pellet in 
acidic calcium phosphate solution for 1, 3 and 5 hours) 
Characterization of DCPD-coated β-TCP pellet (XRD, FTIR, FESEM, AFM, 
porosity, compression test, ICP-OES and pH analysis 
Specimen treated for 3 hours using both concentration of acidic calcium 
phosphate solution were selected for assessment of HAp formation in HBSS 
solution at 37°C (1,3 and 7 days) 
Characterization of HAp formation (XRD, FTIR, FESEM and AFM) 
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CHAPTER 2  
 
 
LITERATURE REVIEW 
 
2.1 Introduction of bioceramics as bone substitute materials for clinical 
            application 
Bioceramics is a type of ceramics with biological functionality and its classify 
as the advanced ceramics material, product or component that utilize in wide range of 
clinical application. Usually, bioceramics is used for repairing and replacing the 
damaged of bone tissues depending on the application. Since the human and animal 
bodies consist of bioceramics such as teeth and bone, this bioceramics give an out-
standing application to replace various bioceramics parts. Moreover, bioceramics have 
the properties of biocompatibility and bioactive which helps in the interaction with the 
surrounding tissues in the body either by supporting tissue growth or by inducing new 
bone formation. Some of the clinical application of bioceramics that has been widely 
used are hip prosthesis, cardiac valves and dental implants which due to their great 
inertness to physiological fluids, having a high compressive strength and give the 
aesthetic value (Shanmugam & Sahadevan, 2018). 
Besides, bioceramics can act as a bioinert ceramics where it remains inactive 
in mechanical load carrier application (Roy, Bandyopadhyay, & Bose, 2016). In 
addition, there various types of biological interaction that should be considered 
between the materials and the body immune system. First, the toxicity of the materials 
which tissues could die due to the chemical leaching from the ceramics. This reaction 
usually happens when the tissue are react with implanted material and shows an 
inflammatory response where it is usually develop around 2 to 7 days after 
implantation . Second, the biologically inert of the materials which the tissues can 
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forms a non-adherent fibrous capsule around the implant surface. In other words, 
introducing a bioinert materials to the body and will not cause any harmful reaction. 
Third, bioactive materials which the tissue can chemically make a bonding with the 
surface of implants. The bonding was due to the formation of hydroxyapatite on the 
materials when immersed in body fluid (Mohamed, El-Aziz, & Breitinger, 2019).  
An osteoconductive material is one of the bioactive materials where the 
material can makes a bond with the hard tissues and stimulate the new bone formation. 
The bond formed are strong due to the similar apatite layer in host bone (Hench & 
Jones, 2005). Lastly, the dissolution of implant in which the surface of implant 
dissolves and allow tissues to fully spread into the space occupied by the implant 
before. The main bioactivity mechanism of calcium phosphate (CaP) is dissolution and 
release of ionic products where it is mainly depends on their chemical composition. 
Studied by Eliaz and Metoki, (2017) mentioned that CaP material such as HAp, TCP 
and OCP are not easily dissolve in vivo. However, in body fluids, OCP and TCP 
dissolve much faster than HAp. The statement was proved by Leó and Jansen, (2009) 
where usually implants made up of HAp are often remains several years in the body 
and the dissolution are expected to be significant. Table 2.1 has classified various type 
of bioceramics and its clinical application as a bone substitute. 
 
 
 
 
 
 
